Document 2432
 DOCN  M94A2432
 TI    The prevalence of HIV, hepatitis B and hepatitis C in a prenatal clinic
       for drug using women.
 DT    9412
 AU    Mitchell JL; Ozick L; Jacobs L; Baroudy B; Harlem Hospital, NYC.
 SO    Int Conf AIDS. 1994 Aug 7-12;10(1):305 (abstract no. PC0148). Unique
       Identifier : AIDSLINE ICA10/94370143
 AB    OBJECTIVE: To determine the prevalence of HIV, Hepatitis B (HBV), and
       Hepatitis C (HCV) in a population of pregnant women at high risk for all
       three. METHODS: All women enrolled in a special prenatal clinic for
       chemically dependent women were encouraged to test for HIV and routinely
       screened for HBV as per a state regulation. In January of 1993, routine
       screening for HCV was begun. If the initial tests were negative, repeat
       testing was done for HBV and HCV at 28 and 36 weeks of gestation. HIV
       testing was repeated at 36 weeks. RESULTS: Of the total number of women
       for which all three test results were available, 25% were positive for
       HIV. Twelve percent were positive for HCV and only 2% were positive for
       HBV. Seven percent were positive for both HIV and HCV. Women with a
       history of injection drug use were more likely to be both HIV and HCV
       infected. DISCUSSION: HCV is emerging as a more significant health
       problem than HBV because of its relationship to chronic liver disease.
       While concern has been expressed in the obstetrical community, the
       significance of this disease, HIV infection; and the possible impact on
       the newborn has yet to be explored.
 DE    Ambulatory Care Facilities  Female  Hepatitis B/*EPIDEMIOLOGY  Hepatitis
       C/*EPIDEMIOLOGY  Human  HIV Infections/*EPIDEMIOLOGY  New York
       City/EPIDEMIOLOGY  Pregnancy  Pregnancy Complications,
       Infectious/*EPIDEMIOLOGY  Prenatal Care  Prevalence  MEETING ABSTRACT

       SOURCE: National Library of Medicine.  NOTICE: This material may be
       protected by Copyright Law (Title 17, U.S.Code).